13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q1 2026. See the latest, Q3 2026 →

Reported value

$3.38B

−25% on the quarter before

Positions

70

31 new, 23 sold out

Top 10

55.6%

of the value

Est. gain

−$98.7M

on stocks held all quarter

Est. return

−4.6%

on those stocks since Q4 2025

Filed

May 15, 2026

On SEC EDGAR ↗

Positions as of Mar 31, 2026, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.

46 others20%
Natera Inc18%
Insmed Inc5.6%
TSMC5.0%
Ishares IncCALL4.8%
Invesco Exchange Traded Fd TCALL4.7%
Ypf Sociedad Anonima4.4%
Ishares Inc3.9%
Bbb Foods Inc3.3%
Alcoa2.9%
Newamsterdam Pharma Company2.9%
Sea2.7%STMicroelectronics2.7%
Woodward Inc2.2%
Teva Pharmaceutical Inds Ltd2.1%
Roku2.1%Broadcom1.8%
State Str SPDR S&P 500 ETF T1.7%
Coupang1.5%
Option Care Health Inc1.5%
Amazon1.2%CRH plc1.2%
Figure Technology Solutio1.2%
Global X Fds1.1%
Caris Life Sciences Inc1.0%

Largest buys

Since Q4 2025, sized at quarter-end prices.

  1. Invesco Exchange Traded Fd TCALL~$157.6MNew, 0.0% → 4.7% of the portfolio+821,000 underlying
  2. Ypf Sociedad Anonima~$121.5MAdded, 0.5% → 4.4% of the portfolio+2,628,972 shares
  3. Natera Inc~$110.4MAdded, 12.8% → 18.1% of the portfolio+552,249 shares
  4. STMicroelectronics~$63.5MAdded, 0.4% → 2.7% of the portfolio+1,839,325 shares
  5. Broadcom~$60.6MNew, 0.0% → 1.8% of the portfolio+195,955 shares
  6. Global X Fds~$36.2MNew, 0.0% → 1.1% of the portfolio+387,400 shares
  7. Caris Life Sciences Inc~$33.9MNew, 0.0% → 1.0% of the portfolio+1,894,450 shares
  8. Revolution Medicines Inc~$30.7MNew, 0.0% → 0.9% of the portfolio+315,860 shares
  9. Sandisk~$24.2MNew, 0.0% → 0.7% of the portfolio+38,155 shares
  10. Humana~$23.8MNew, 0.0% → 0.7% of the portfolio+137,505 shares

Largest sells

Since Q4 2025, sized at quarter-end prices.

  1. Select Sector SPDR Tr~$301.0MSold out, 6.7% → 0.0% of the portfolio−5,495,600 shares
  2. Invesco Exchange Traded Fd T~$224.9MSold out, 5.0% → 0.0% of the portfolio−1,173,925 shares
  3. Amazon~$144.2MCut, 3.8% → 0.3% of the portfolio−692,140 shares
  4. Woodward Inc~$135.9MCut, 4.0% → 2.2% of the portfolio−379,575 shares
  5. Alphabet~$120.5MSold out, 2.7% → 0.0% of the portfolio−385,000 shares
  6. Teva Pharmaceutical Inds Ltd~$105.3MCut, 4.1% → 2.1% of the portfolio−3,497,585 shares
  7. Bloom Energy~$81.9MCut, 1.4% → 0.5% of the portfolio−604,225 shares
  8. Cogent Biosciences Inc~$78.7MSold out, 1.8% → 0.0% of the portfolio−2,214,470 shares
  9. Coupang~$77.5MCut, 3.6% → 1.5% of the portfolio−4,105,424 shares
  10. MercadoLibre~$76.7MCut, 2.1% → 0.1% of the portfolio−44,383 shares

Holdings

As of Mar 31, 2026; changes in shares since Dec 31, 2025.

Positions, sorted by share of the portfolio
HoldingValue
Natera IncCOM · shares +22% · price −12.7%18.1%$612.7M−$73.1M
Insmed IncCOM PAR $.01 · shares −22% · price −6.0%5.6%$188.7M−$12.1M
TSMCSPONSORED ADS · shares −8.8% · price +11.2%5.0%$167.4M+$16.9M
Ishares IncCALLMSCI BRAZIL ETF · shares 0%4.8%$162.3M—
Invesco Exchange Traded Fd TCALLS&P500 EQL WGT · shares New4.7%$157.6M—
Ypf Sociedad AnonimaSPON ADR CL D · shares +433% · price +27.8%4.4%$149.6M+$6.1M
Ishares IncMSCI BRAZIL ETF · shares −3.3% · price +20.8%3.9%$131.9M+$22.7M
Bbb Foods IncCL A COM · shares +16% · price +5.9%3.3%$110.0M+$5.3M
AlcoaCOM · shares +8.5% · price +24.8%2.9%$99.1M+$18.2M
Newamsterdam Pharma CompanyORDINARY SHARES · shares 0% · price −8.8%2.9%$98.3M−$9.4M
SeaSPONSORD ADS · shares +17% · price −35.1%2.7%$91.1M−$42.3M
STMicroelectronicsNY REGISTRY · shares +238% · price +33.2%2.7%$90.3M+$6.7M
Woodward IncCOM · shares −64% · price +18.4%2.2%$75.6M+$11.8M
Teva Pharmaceutical Inds LtdSPONSORED ADS · shares −60% · price −3.5%2.1%$71.6M−$2.6M
RokuCOM CL A · shares +29% · price −12.8%2.1%$71.0M−$8.1M
BroadcomCOM · shares New1.8%$60.6M—
State Str SPDR S&P 500 ETF TCALLTR UNIT · shares 0%1.7%$58.5M—
CoupangCL A · shares −61% · price −20.0%1.5%$50.4M−$12.6M
Option Care Health IncCOM NEW · shares +7.0% · price −15.5%1.5%$50.3M−$8.6M
AmazonCALLCOM · shares +100%1.2%$41.7M—
CRH plcORD · shares −21% · price −15.8%1.2%$39.7M−$7.4M
Figure Technology SolutioCOM CL A · shares −25% · price −16.9%1.2%$39.1M−$7.9M
Global X FdsGB MSCI AR ETF · shares New1.1%$36.2M—
Caris Life Sciences IncCOM · shares New1.0%$33.9M—
Restaurant Brands Intl IncCOM · shares −62% · price +8.3%0.99%$33.6M+$2.6M
Total 70 positions100%$3.38B−$98.7M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2025 to Q1 2026: 35 stocks held throughout, down $98.7M (−4.6%).

  1. Ishares Inc+$22.7M+21%
  2. Alcoa+$18.2M+25%
  3. TSMC+$16.9M+11%
  4. Woodward Inc+$11.8M+18%
  5. Adma Biologics Inc6:1 split+$9.0M+196%
  6. Stubhub Hldgs Inc−$10.0M−54%
  7. Insmed Inc−$12.1M−6%
  8. Coupang−$12.6M−20%
  9. Sea−$42.3M−35%
  10. Natera Inc−$73.1M−13%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free